库尔库米诺类药物作为亡的自然调节剂:治疗含义
Zahra Foroutan1, Arrigo Francesco Giuseppe Cicero2,3, Tannaz Jamialahmadi4,5
1Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Naunyn-Schmiedeberg's archives of pharmacology
|September 17, 2024
概括
来自黄的库尔库米诺类药物在亡 (编程细胞死亡) 中表现出双重作用. 它们在组织损伤中抑制死细胞灭绝,但在癌细胞中诱导它,提供治疗潜力.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 亡是一种由RIPK1/RIPK3激酶和MLKL启动的炎症编程细胞死亡途径.
- 来自黄的库尔库米诺类药物表现出各种治疗性质,如抗癌和抗炎作用.
研究的目的:
- 探索库尔库米诺和亡分子机制之间的关系.
- 审查体内和体外研究中的米诺类药物在亡中的作用.
主要方法:
- 在体内和体外研究的文献综述.
- 对类药物对关键亡指标的影响分析.
主要成果:
- 库尔库米诺类药物在组织损伤时起到亡抑制剂的作用.
- 库尔库米诺类药物在癌细胞中充当死亡诱导剂.
- 库尔库米诺类药物调节了临界亡途径的组成部分.
结论:
- 库尔库米诺类药物在亡中具有双重作用,具有重要的治疗意义.
- 为了推进疾病治疗策略,需要对类药物进行进一步的研究.
相关概念视频
The Extrinsic Apoptotic Pathway
6.3K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K
Necrosis
4.4K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.4K
Phagocytosis of Apoptotic Cells
3.7K
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized...
Normal cells contain receptors that prevent them from being recognized...
3.7K
NF-κB-dependent Signaling Pathway
7.3K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.3K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K


